Ferulic acid ethosomes co-modified with astragaloside iv and ceramide iiib

Intervention

1 paper3 findings

  • 1 lab in 1 country
  • Animals1

Outcomes

3

Lipofuscin

downin worms1

1 study
  1. Ferulic acid ethosomes co-modified with astragaloside iv and ceramide iiib decreases lipofuscin in worms.

    “reduced lipofuscin accumulation, and improved resistance to oxidative stress and high-temperature conditions”

    Model organisms

    Astragaloside IV and ceramide IIIB co-modified ferulic acid ethosomes: a promising novel approach for skin anti-aging

    Journal of liposome research8 Dec 2025

More on Lipofuscin

Lifespan

upin worms1

1 study
  1. Ferulic acid ethosomes co-modified with astragaloside iv and ceramide iiib extends lifespan in worms.

    “In C. elegans models, FA-ES increased transdermal absorption efficiency, extended lifespan”

    Model organisms

    Astragaloside IV and ceramide IIIB co-modified ferulic acid ethosomes: a promising novel approach for skin anti-aging

    Journal of liposome research8 Dec 2025

Senescence-associated beta-galactosidase

downin zebrafish1

1 study
  1. Ferulic acid ethosomes co-modified with astragaloside iv and ceramide iiib decreases senescence-associated beta-galactosidase in zebrafish.

    “Comparative studies in zebrafish models showed FA-ES significantly reduced embryonic toxicity and β-galactosidase activity”

    Animals

    Astragaloside IV and ceramide IIIB co-modified ferulic acid ethosomes: a promising novel approach for skin anti-aging

    Journal of liposome research8 Dec 2025

More on Senescence-associated beta-galactosidase

Latest

Nov 2025: 0Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months